CGON Overview
Upcoming Projects (CGON)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CGON)
-
A second look at novel therapeutics in development for NMIBC, including; Cretostimogene, TAR-200, TAR-210 Erdafitinib Intravesical Delivery System, and UGN-102
Tickers: CGON, JNJ, URGN
Executed On: Jun 25, 2024 at 11:00 AM EDT -
A look at novel therapeutics in development for NMIBC, including; Cretostimogene, TAR-200 and the TAR-210 Erdafitinib Intravesical Delivery System.
Tickers: CGON, JNJ
Executed On: Jun 06, 2024 at 05:00 PM EDT -
Discussing CG Oncology's CORE-001 Phase 2 Trial of Cretostimogene Combined with Pembrolizumab for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer presented at ASCO 2024
Ticker: CGON
Executed On: Jun 04, 2024 at 11:00 AM EDT
Upcoming & Overdue Catalysts (CGON)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (CGON)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
